Stocks · Health care · Pharmaceutical Preparations

CYPHERPUNK TECHNOLOGIES INC.

CYPH Clue Score23
United States Fiscal year ends December CIK 0001509745
$2.94 +4.63% Close, 9 Oct 2026
Price $2.94 −8.98% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 25 Jan 2017. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Operating income−27.3Net income−25.6Fiscal year 2017Operating income−32.4Net income−29.7EPS, diluted−3.31Fiscal year 2018Operating income−30.8Net income−23.1EPS, diluted−2.11Fiscal year 2019Operating income−33.5Net income−32.9EPS, diluted−1.47Fiscal year 2020Revenue1.5Operating income−28.5Net income−27.5EPS, diluted−0.63Fiscal year 2021Revenue1.5 +0.0%Operating income−41.4Net income−40.6EPS, diluted−0.47Fiscal year 2022Operating income−56.8Net income−54.6EPS, diluted−4.82Fiscal year 2023Operating income−87.0Net income−81.4EPS, diluted−3.98Fiscal year 2024Operating income−70.1Net income−67.6EPS, diluted−1.81Fiscal year 2025Operating income−41.1Net income4.8EPS, diluted0.07
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue n/a n/a n/a n/a 1.5 1.5 n/a n/a n/a n/a
Growth +0.0%
Operating income −27.3 −32.4 −30.8 −33.5 −28.5 −41.4 −56.8 −87.0 −70.1 −41.1
Net income −25.6 −29.7 −23.1 −32.9 −27.5 −40.6 −54.6 −81.4 −67.6 4.8
Growth
EPS, diluted n/a −3.31 −2.11 −1.47 −0.63 −0.47 −4.82 −3.98 −1.81 0.07

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2016Fiscal year 2017Fiscal year 2018Fiscal year 2019Fiscal year 2020Operating margin−1,902.6%Net margin−1,834.3%Fiscal year 2021Operating margin−2,761.7%Net margin−2,705.8%Fiscal year 2022Fiscal year 2023Fiscal year 2024Fiscal year 2025
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin n/a n/a n/a n/a −1,902.6% −2,761.7% n/a n/a n/a n/a
Net margin n/a n/a n/a n/a −1,834.3% −2,705.8% n/a n/a n/a n/a

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow−25.3Capital expenditure−0.1Free cash flow−25.5Fiscal year 2017Operating cash flow−22.1Capital expenditure−0.1Free cash flow−22.2Fiscal year 2018Operating cash flow−26.0Fiscal year 2019Operating cash flow−26.9Capital expenditure−0.1Free cash flow−27.0Fiscal year 2020Operating cash flow−26.0Fiscal year 2021Operating cash flow−35.2Fiscal year 2022Operating cash flow−49.0Fiscal year 2023Operating cash flow−43.8Fiscal year 2024Operating cash flow−60.3Fiscal year 2025Operating cash flow−43.9
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −25.3 −22.1 −26.0 −26.9 −26.0 −35.2 −49.0 −43.8 −60.3 −43.9
Capital expenditure −0.1 −0.1 n/a −0.1 n/a n/a n/a n/a n/a n/a
Free cash flow −25.5 −22.2 n/a −27.0 n/a n/a n/a n/a n/a n/a
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2016Cash0.8Shareholders’ equity−100.2Fiscal year 2017Cash25.7Shareholders’ equity11.1Fiscal year 2018Cash16.3Shareholders’ equity9.2Fiscal year 2019Cash3.9Shareholders’ equity−1.7Fiscal year 2020Cash52.1Shareholders’ equity46.7Fiscal year 2021Cash114.9Shareholders’ equity107.9Fiscal year 2022Cash65.5Shareholders’ equity58.9Fiscal year 2023Cash70.6Shareholders’ equity60.1Fiscal year 2024Cash47.2Shareholders’ equity35.0Fiscal year 2025Cash14.0Shareholders’ equity153.5
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 0.8 25.7 16.3 3.9 52.1 114.9 65.5 70.6 47.2 14.0
Shareholders’ equity −100.2 11.1 9.2 −1.7 46.7 107.9 58.9 60.1 35.0 153.5

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Cash flow

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018† 31 Dec 2018 FY2019† 31 Dec 2019 FY2020† 31 Dec 2020 FY2021 31 Dec 2021 FY2022† 31 Dec 2022 FY2023† 31 Dec 2023 FY2024† 31 Dec 2024 FY2025† 31 Dec 2025
Operations
−25.3 −22.1 −26.0 −26.9 −26.0 −35.2 −49.0 −43.8 −60.3 −43.9
Growth
Investment
−0.1 −0.1 n/a −0.1 n/a n/a n/a n/a n/a n/a
calc −25.5 −22.2 n/a −27.0 n/a n/a n/a n/a n/a n/a
Growth
calc n/a −2.42 n/a −1.20 n/a n/a n/a n/a n/a n/a
−0.1 −0.1 n/a −0.1 0.0 n/a n/a 49.0 n/a −97.0
Financing
25.6 47.8 15.9 14.8 74.0 98.0 −0.2 −0.0 37.2 107.6

† The diluted share count jumps at 2018 and 2019 and 2020 and 2022 and 2023 and 2024 and 2025, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Lines marked calc are worked out here from filed figures; point at one for how. Capital expenditure, dividends and buybacks are shown as money out, so negative.